ENTITY
Sanofi ADR

Sanofi ADR (SNY US)

82
Analysis
Health CareUnited States
Sanofi is a global pharmaceutical company that researches, develops and manufactures prescription pharmaceuticals and vaccines. The Company develops cardiovascular, thrombosis, metabolic disorder, central nervous system, internal medicine and oncology drugs, and vaccines.
more
Refresh
09 Sep 2019 08:22

Global Equity Strategy: Guarded Optimism

Global equities (MSCI ACWI) are decisively breaking above 1-month resistance on US-China trade war optimism, incrementally improving the technical...

Logo
381 Views
Share
28 Feb 2019 04:23

Amarin Q4 2018 Conference Call--Strong Sales & High Confidence

Q4 2018 Revenues Stronger Than Pre-Announcement on January 4th: Amarin released its Q4 2018 results today and held a conference call. Results of...

Logo
678 Views
Share
07 Jan 2019 11:15

Amarin--2019's Biggest Buyout Target for Big Pharma

Amarin (AMRN US), a US-listed biotech firm, presented the full results of its "Reduce-It" (RI) clinical trial at a conference for the American...

Logo
4.7k Views
Share
bearishMSCI ACWI Index
12 Dec 2018 08:45

Global Equity Strategy: Cautious Outlook Intact; Defensive Sectors Remain Leadership

Global equities (MSCI ACWI) are testing 52-week lows as prices have been consolidating over the last 1-2 months. Our outlook for global equities...

Logo
542 Views
Share
bullishWuXi AppTec
21 Nov 2018 10:41

Wuxi Apptec 药明康德 IPO: Welcome to the A/H Universe

WuXi Apptec is set to be the newest A/H pair with its upcoming HK listing that is set to raise USD 1 billion. The A-share (603289 CH) recorded 15...

Share
x